Drugs / AMG 581
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02504476 | Aug 2015 → Feb 2016 | psychotic disorder | Amgen | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02567370 Comparator | Aug → Oct 2015 | psychotic disorder | Amgen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 581 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02567370 ↗ |
| Route | Oral | “ascending multiple oral doses of AMG 581” NCT02504476 ↗ |